THPO and Thrombocytopenia: Both rhTPO and MGDF were effective in raising platelet counts in different clinical settings [31–36]; however, their clinical development was halted following development of neutralizing antibodies against MGDF that led to persistent thrombocytopenia in some individuals [37].